Searched for
JUNEJA BROTHERS
Mankind Pharma’s Rx for success: Aatmanirbhar push, affordable careMankind Pharma, guided by Ramesh and Rajeev Juneja, is a leading Indian pharmaceutical firm. The company focuses on mass-market drugs and h...
Next-gen leaders look beyond legacy, back professionals for family officesYoung leaders in Indian family businesses are forging their own paths. They are building new ventures while handing over family office mana...
Dealmaker Rajeev Misra’s son sets out with a $150 million fundRohan Misra, son of former SoftBank Vision Fund chief executive Rajeev Misra, is launching his own fund, Gravity Holdings. The London-based...
Lenders issue LoI to INSCO after SC order in Hindusthan National Glass caseState Bank of India has approved INSCO's takeover of Hindusthan National Glass after AGI Greenpac failed to get CCI approval. INSCO has unt...
Tatas to enter red-hot quick commerce space with ‘Neu Flash’Joining Flipkart and Reliance Industries, salt-to-software conglomerate Tata Group is set to enter the ever-growing quick commerce sector a...
SoftBank’s Alex Clavel interview; Nvidia’s India chipHappy Tuesday! Alex Clavel, the top boss at SoftBank Vision Fund, spoke to ETtech in an exclusive interview. This and other updates in toda...
Mankind: How Meerut brothers built India's 4th largest pharma firmMankind Pharma has announced a significant move by acquiring Bharat Serums and Vaccines Ltd for Rs 13,630 crore. The acquisition, partly fu...
Mankind can clear debt taken for BSV buy in 3 years: MD Rajeev JunejaMankind Pharma aims to clear its ₹13,630-crore debt from acquiring Bharat Serums and Vaccines within three years, according to MD Rajeev Ju...
Mankind joins race for Apax's surgical supplies company Healthium MedtechBidding for Healthium is likely to be competitive with several others such as KKR, Novo Nordisk, Hillhouse, Blackstone and EQT said to be a...
Mankind Pharma stock falls 3% as PE investors likely sell 1.3 crore sharesPE firm ChrysCapital's affiliate entity Beige Ltd was reported to have issued a term sheet via its broker to sell up to 1.16 crore shares o...
Resilience and ambition have got us to where we are today, say Mankind’s Juneja brothersIntroducing pocket-friendly medicines in a price-sensitive market like India was a revolutionary strategy that made a big difference. "It t...
Carlsberg, Nirma, PEs in race for bottlemaker HNGDanish beer maker Carlsberg, private equity funds Oaktree Capital and Cerberus, Nirma Chemicals and SNJ Distilleries are among a dozen enti...
Mankind Pharma plans $1 billion IPO, hires bankersIn the proposed offer for sale, existing investors ChrysCapital will sell about 1% stake, Capital International will sell another 6% while ...
Fintso brings on board ex-Wall Street fund manager Soumyo Sarkar to advisory councilThe Wall Street professional has experience of over 35 years working with leading firms like Credit Suisse, Deutsche Bank, Merrill Lynch, S...
The story of Juneja siblings, the biggest disruptors in Indian pharma spaceThese former medical representatives have consistently struck gold at the bottom of the pyramid, selling drugs everywhere, priced lower tha...
- Vodafone case: PIL claims conflict of interest by CJI
A petition filed in the SC has sought a reconsideration of the apex court's judgment quashing the Rs 11,000 crore tax demand on Vodafone
- Binani Cement forays into realty
Binani Cement - the flagship company of the Binani Group - is getting into commercial real estate development in order to cash in on its id...
- Mankind Pharma's pocket-friendly pricing in demand
It was around 2000, after the company's sales touched Rs 50 crore when Ramesh Juneja, the founder managing director of Mankind Pharma got a...
- Going the extra mile
Mankind Pharma’s Juneja says he did a service to consumers by cutting prices, and they returned the favour in cash.
- Mankind Pharma eyes upto 10% equity sale
Unlisted drug maker Mankind Pharma Ltd hopes this year to sell upto 10 per cent of its equity to domestic investors in a bid to raise funds...